APA (7th ed.) Citation

S, V. L., K, S., M, G., E, B., A, C., L, C., . . . S, H. (2025). State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases. European journal of heart failure, 27(1), 5. https://doi.org/10.1002/ejhf.3516

Chicago Style (17th ed.) Citation

S, Van Linthout, et al. "State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases." European Journal of Heart Failure 27, no. 1 (2025): 5. https://doi.org/10.1002/ejhf.3516.

MLA (9th ed.) Citation

S, Van Linthout, et al. "State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases." European Journal of Heart Failure, vol. 27, no. 1, 2025, p. 5, https://doi.org/10.1002/ejhf.3516.